Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves
- Getting Gen-Y on Boards (of Directors) also published in forbes.com
- Ackman Expects 'Influence' in Air Products CEO Search also written by Antoine Gara
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Family Dollar Sees 'Virtual Certainty' Of Antitrust Clearance For Dollar Tree Merger also written by Antoine Gara
- Six Years Later, The Problem at HP is Still the Board also published in forbes.com
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
Login to comment.